Delivery Order SPE2DB20D3101-SPE2DB23FRCN0

Award Date 2/13/23
Potential Completion Date 2/14/23
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ULORIC 80 MG TABLET 30S, a prescription medication. The contract has a ceiling value of $1,210.93 and is a firm fixed-price contract with a period of performance through June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.59, is for the delivery of ULORIC 40 MG TABLET 30S, a medication used to treat gout. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.48 firm fixed-price delivery order is for the supply of ULORIC 80 MG TABLET 30S, a generic pharmaceutical product. The contract has a completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,759.96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ULORIC 80 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $2,077.25 and runs through November 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. This delivery order is likely part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,810.20, is for the delivery of 4563458673 ULORIC 40 MG TABLET 30S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564450183 ULORIC 40 MG TABLET 30S. The $2,802.33 firm-fixed-price contract has a completion date of May 1, 2024 and was awarded on April 30, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB24FQ3M5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565862279 ULORIC 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,621.50 and a completion date of September 19, 2024. This is a firm fixed-price delivery order contract, and no set-aside was used. Amerisourcebergen, a major pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp (ABDC) by the Defense Logistics Agency (DLA) Troop Support Medical under the DLA's Indefinite Delivery Contract (IDC) valued at up to $999,999,999. The delivery order, valued at $1,124.14, is for the supply of 4565256367 ULORIC 80 MG TABLET 30S, a prescription medication. The contract has a firm fixed price and is set to expire on July 26, 2024. This award is not set-aside. As a major pharmaceutical distributor, ABDC leverages its...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRCN0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Uloric 80 mg tablets, a medication used to treat gout. The contract has a ceiling value of $1,909.44 and runs through February 14, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 12:13 PM